chr14-74494829-AT-A
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PVS1_StrongPM2PP5
The NM_194279.4(ISCA2):c.297del(p.Phe99LeufsTer18) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000663 in 1,613,716 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000069 ( 0 hom. )
Consequence
ISCA2
NM_194279.4 frameshift
NM_194279.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.83
Genes affected
ISCA2 (HGNC:19857): (iron-sulfur cluster assembly 2) The protein encoded by this gene is an A-type iron-sulfur cluster (ISC) protein found in mitochondria. The encoded protein appears to be involved in the maturation of mitochondrial iron-sulfur proteins. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.366 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 14-74494829-AT-A is Pathogenic according to our data. Variant chr14-74494829-AT-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 545531.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=1, not_provided=1, Uncertain_significance=1}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ISCA2 | NM_194279.4 | c.297del | p.Phe99LeufsTer18 | frameshift_variant | 4/4 | ENST00000556816.6 | NP_919255.2 | |
ISCA2 | NM_001272007.2 | c.181del | p.Ter61GlufsTer56 | frameshift_variant | 3/3 | NP_001258936.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ISCA2 | ENST00000556816.6 | c.297del | p.Phe99LeufsTer18 | frameshift_variant | 4/4 | 1 | NM_194279.4 | ENSP00000452007 | P1 | |
ISCA2 | ENST00000554924.1 | c.181del | p.Ter61GlufsTer56 | frameshift_variant | 3/3 | 2 | ENSP00000450523 | |||
ISCA2 | ENST00000298818.12 | c.305-7del | splice_polypyrimidine_tract_variant, intron_variant | 5 | ENSP00000298818 | |||||
ISCA2 | ENST00000555139.1 | n.735del | non_coding_transcript_exon_variant | 3/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152106Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
6
AN:
152106
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 250972Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135616
GnomAD3 exomes
AF:
AC:
7
AN:
250972
Hom.:
AF XY:
AC XY:
4
AN XY:
135616
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000691 AC: 101AN: 1461610Hom.: 0 Cov.: 31 AF XY: 0.0000619 AC XY: 45AN XY: 727118
GnomAD4 exome
AF:
AC:
101
AN:
1461610
Hom.:
Cov.:
31
AF XY:
AC XY:
45
AN XY:
727118
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152106Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74294
GnomAD4 genome
AF:
AC:
6
AN:
152106
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
74294
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:1Other:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Pathogenic:1Uncertain:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 28, 2018 | The c.297delT variant has been published in a two month old presenting with severe hypotonia and nystagmus who had decreased activities of complex II and IV in muscle tissue and who harbored a second variant in the ISCA2 gene on the opposite allele (in trans) (Toldo et al., 2018). The c.297delT variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). The c.297delT variant causes a frameshift starting with codon Phenylalanine 99, changes this amino acid to a Leucine residue and creates a premature Stop codon at position 18 of the new reading frame, denoted p.Phe99LeufsX18 (F99LfsX18). This variant is predicted to cause loss of normal protein function through protein truncation. In summary, we interpret c.297delT as a likely pathogenic variant. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 30, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 545531). This premature translational stop signal has been observed in individual(s) with clinical features consistent with multiple mitochondrial dysfunctions syndrome (PMID: 29359243). This variant is present in population databases (rs778755775, gnomAD 0.007%). This sequence change creates a premature translational stop signal (p.Phe99Leufs*18) in the ISCA2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 56 amino acid(s) of the ISCA2 protein. - |
Multiple mitochondrial dysfunctions syndrome 4 Pathogenic:1Other:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 15, 2018 | - - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at